The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels
Abstract
IMPORTANCE: Rates of testosterone therapy are increasing and the effects of testosterone therapy on cardiovascular outcomes and mortality are unknown. A recent randomized clinical trial of testosterone therapy in men with a high prevalence of cardiovascular diseases was stopped prematurely due to adverse cardiovascular events raising concerns about testosterone therapy safety. OBJECTIVES: To assess the association between testosterone therapy and all-cause mortality, myocardial infarction (MI), or stroke among male veterans and to determine whether this association is modified by underlying coronary artery disease. DESIGN, SETTING, AND PATIENTS: A retrospective national cohort study of men with low testosterone levels (<300 ng/dL) who underwent coronary angiography in the Veterans Affairs (VA) system between 2005 and 2011. MAIN OUTCOMES AND MEASURES: Primary outcome was a composite of all-cause mortality, MI, and ischemic stroke. RESULTS: Of the 8709 men with a total testosterone level lower than 300 ng/dL, 1223 patients started testosterone therapy after a median of 531 days following coronary angiography. Of the 1710 outcome events, 748 men died, 443 had MIs, and 519 had strokes. Of 7486 patients not receiving testosterone therapy, 681 died, 420 had MIs, and 486 had strokes. Among 1223 patients receiving testosterone therapy, 67 died, 23 had MIs, and 33 had strokes. At 3 years after coronary angiography, the Kaplan-Meier estimated cumulative percentages with events were 19.9%in the no testosterone therapy group vs 25.7%in the testosterone therapy group,with an absolute risk difference of 5.8%(95%CI, -1.4%to 13.1%) [corrected].The Kaplan-Meier estimated cumulative percentages with events among the no testosterone therapy group vs testosterone therapy group at 1 year after coronary angiography were 10.1% vs 11.3%; at 2 years, 15.4% vs 18.5%; and at 3 years, 19.9% vs 25.7 [corrected].There was no significant difference in the effect size of testosterone therapy among those with and without coronary artery disease (test for interaction, P = .41). CONCLUSIONS AND RELEVANCE: Among a cohort of men in the VA health care system who underwent coronary angiography and had a low serum testosterone level, the use of testosterone therapy was associated with increased risk of adverse outcomes. These findings may inform the discussion about the potential risks of testosterone therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the authors identified a higher rate of AEs in the T supplementation group (after statistical manipulation of the raw data), given the wide discrepancy in groupings, it is unclear if this group represented men with a higher baseline risk for subsequent events and that a lower T in this group was an indirect indicator of their overall comorbid burdens (despite lower ages).”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [129]
In the citing paper
“Additionally, groupings were not matched for age or T levels.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [129]
In the citing paper
“One recent example of poorly matched groupings was the Vigen et al’s retrospective analysis of a VA population, which compared hypogonadal men receiving or not receiving T supplementation.129 Baseline comorbid states were significantly different between groupings, including obesity, obstructed coronary artery status, hypertension, hyperlipidemia, myocardial infarction, and cerebrovascular disease,”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [129]
In the citing paper
“Some epidemiological studies have reported an increase in cardiovascular mortality related to TRT while others have not been able to establish a correlation between the two [19,20].”
Citations
Cites
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article
Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,213
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Immortal Time Bias in Pharmacoepidemiology
Suissa, S. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm324 · Cited by 1,837
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R., Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., & Ross, C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3988 · Cited by 920
Calof, O. M., Singh, A. B., Lee, M. L., Kenny, A. M., Urban, R. J., Tenover, J. L., & Bhasin, S. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.11.1451 · Cited by 728
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
Fernández-Balsells, M. M., Murad, M. H., Lane, M., Lampropulos, J. F., Albuquerque, F., Mullan, R. J., Agrwal, N., Elamin, M. B., Gallegos-Orozco, J. F., Wang, A. T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2575 · Cited by 713
Isidori, A. M., Giannetta, E., Greco, E. A., Gianfrilli, D., Bonifacio, V., Isidori, A., Lenzi, A., & Fabbri, A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02339.x · Cited by 695
Effects of Testosterone Replacement in Hypogonadal Men1
Snyder, P. J., Peachey, H., Berlin, J. A., Hannoush, P., Haddad, G., Dlewati, A., Santanna, J., Loh, L., Lenrow, D. A., Holmes, J. H., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6731 · Cited by 610
Jones, T. H., Arver, S., Behre, H. M., Buvat, J., Meuleman, E., Moncada, I., Morales, A. M., Volterrani, M., Yellowlees, A., Howell, J. D., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1233 · Cited by 548
Cited by
Sorted by citations
Items 301–400 of 999
Jasuja, G. K., Ameli, O., Reisman, J. I., Rose, A. J., Miller, D. R., Berlowitz, D. R., & Bhasin, S. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17141 · Cited by 28
Between mind and heart: Sex-based cognitive bias in cardiovascular disease treatment
Kentner, A. C., & Grace, S. L. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.02.002 · Cited by 29
Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans
Tchernof, A., Brochu, D., Maltais‐Payette, I., Mansour, M. F., Marchand, G. B., Carreau, A., & Kapeluto, J. (2018) · Comprehensive physiology · doi:10.1002/j.2040-4603.2018.tb00043.x · Cited by 27
Outcomes of testosterone therapy in men with testosterone deficiency (TD): Part II
Traish, A. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.004 · Cited by 27
Testosterone deficiency and cardiovascular mortality
Morgentaler, A. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.143248 · Cited by 28
Could androgens be relevant to partly explain why men have lower life expectancy than women?
Schooling, C. M. (2015) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2015-206336 · Cited by 27
Testosterone deficiency: myth, facts, and controversy.
Miner, M. M., Barkin, J., & Rosenberg, M. T. (2014) · PubMed · Cited by 27
Sansone, A., Rastrelli, G., Cignarelli, A., Ponce, M. D. R., Condorelli, R. A., Giannetta, E., Maseroli, E., Pinto, S., Salzano, C., & Santi, D. (2019) · International Journal of Impotence Research · doi:10.1038/s41443-019-0163-6 · Cited by 27
Medzikovic, L., Azem, T., Sun, W., Rejali, P., Esdin, L., Rahman, S., Dehghanitafti, A., Aryan, L., & Eghbali, M. (2023) · Cells · doi:10.3390/cells12162077 · Cited by 29
The association of testosterone with sarcopenia and frailty in chronic liver disease
Chrysavgis, L., Adamantou, M., Angelousi, A. G., & Cholongitas, Ε. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14108 · Cited by 28
Androgen deficiency and type 2 diabetes mellitus
Gibb, F. W., & Strachan, M. W. J. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.04.004 · Cited by 29
Gagliano‐Jucá, T., İçli, T. B., Pencina, K. M., Li, Z., Tapper, J., Huang, G. T.-W., Travison, T. G., Tsitouras, P. D., Harman, S. M., Storer, T. W., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3669 · Cited by 26
Júnior, R. F. R., Ronconi, K. S., de Jesus, I. C. G., Almeida, P., Forechi, L., Vassallo, D. V., Guatimosim, S., Stefanon, I., & Fernandes, A. A. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.011 · Cited by 28
Yeung, S. L. A., Jiang, C., Cheng, K. K., Xu, L., Zhang, W., Lam, T. H., Leung, G. M., & Schooling, C. M. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.06.006 · Cited by 27
Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure
Peñalver, M. N., Pérez‐Martínez, M. T., Gómez-Bueno, M. F., García‐Pavía, P., Lupón, J., Roig, E. S., Colet, J. C., Bayés‐Genís, A., Velasco, J. A. N., & Pascual-Figal, D. A. (2018) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248418784020 · Cited by 27
Morden, N. E., Woloshin, S., Brooks, C. G., & Schwartz, L. M. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.6505 · Cited by 27
Seftel, A. D. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.11.060 · Cited by 28
An update on the role of testosterone replacement therapy in the management of hypogonadism
Hackett, G. I. (2015) · Therapeutic Advances in Urology · doi:10.1177/1756287215617648 · Cited by 26
Xia, K., Chen, H., Wang, J., Feng, X. G., Gao, Y., Wang, Y., Deng, R., Wu, C., Luo, P., Zhang, M., et al. (2020) · Theranostics · doi:10.7150/thno.46854 · Cited by 26
Testosterone Replacement Therapy: The Emperor's New Clothes
Sansone, A., Sansone, M., Lenzi, A., & Romanelli, F. (2016) · Rejuvenation Research · doi:10.1089/rej.2016.1818 · Cited by 26
Bae, W. J., Zhu, G., Choi, S. W., Jeong, H. C., Bashraheel, F., Kim, K. S., Kim, S. J., Cho, H. J., Ha, U., Hong, S., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6024839 · Cited by 26
Goetz, T. G., Mamillapalli, R., Şahin, Ç., Zolbin, M. M., Ge, G., Mani, A., & Taylor, H. S. (2017) · Endocrinology · doi:10.1210/en.2017-00884 · Cited by 27
Testosterone Replacement Therapy in Men with Prostate Cancer: A Time-Varying Analysis
Kaplan, A. L., Lenis, A. T., Shah, A., Rajfer, J., & Hu, J. C. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12768 · Cited by 26
Neuroendocrine Regulation of Anxiety: Beyond the Hypothalamic‐Pituitary‐Adrenal Axis
Borrow, A. P., Stranahan, A. M., Suchecki, D., & Yunes, R. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12403 · Cited by 27
Huang, G., Travison, T., Maggio, M., Edwards, R. R., & Basaria, S. (2016) · Clinical Endocrinology · doi:10.1111/cen.13049 · Cited by 26
Miller, C., Madden-Doyle, L., Jayasena, C. N., McIlroy, M., Sherlock, M., & O’Reilly, M. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae128 · Cited by 27
Testosterone Treatment in Middle-Aged and Older Men with Hypogonadism
Bhasin, S., & Snyder, P. J. (2025) · New England Journal of Medicine · doi:10.1056/nejmra2404637 · Cited by 27
Testosterone, thrombophilia, thrombosis
Glueck, C. J., Friedman, J., Hafeez, A., Hassan, A., & Wang, P. (2014) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000126 · Cited by 25
Obstructive Sleep Apnea and Testosterone Therapy
Payne, K. S., Lipshultz, L. I., Hotaling, J. M., & Pastuszak, A. W. (2020) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2020.04.004 · Cited by 25
Livingston, M. A., Downie, P., Hackett, G. I., Marrington, R., Heald, A. H., & Ramachandran, S. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13607 · Cited by 25
Graybill, S. D., Hatfield, J., Kravchenko, M. I., Beckman, D., Tate, J. M., Beauvais, A., CLERC, P. G., Davila, D., Forbes, W. L., Wardian, J., et al. (2021) · Andrology · doi:10.1111/andr.12966 · Cited by 41
Late-onset hypogonadism: Clinical evidence, biological aspects and evolutionary considerations
Jaschke, N., Wang, A., Hofbauer, L. C., Rauner, M., & Rachner, T. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101301 · Cited by 30
Nyquist, M. D., Ang, L. S., Corella, A. N., Coleman, I. M., Meers, M. P., Christiani, A. J., Pierce, C., Janssens, D. H., Meade, H. E., Bose, A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci151719 · Cited by 25
van der Burgh, A. C., Khan, S. R., Neggers, S. J. C. M. M., Hoorn, E. J., & Chaker, L. (2022) · Endocrine Connections · doi:10.1530/ec-22-0061 · Cited by 26
Fang, S., Hemani, G., Richardson, T. G., Gaunt, T. R., & Smith, G. D. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac186 · Cited by 24
Grossmann, M., Jayasena, C. N., & Anawalt, B. D. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad180 · Cited by 25
Testosterone therapy and mortality risk
Eisenberg, M. L., Li, S., Herder, D., Lamb, D. J., & Lipshultz, L. I. (2014) · International Journal of Impotence Research · doi:10.1038/ijir.2014.29 · Cited by 25
Serum androgens and risk of atrial fibrillation in older men: The Cardiovascular Health Study
Rosenberg, M. A., Shores, M. M., Matsumoto, A. M., Bůžková, P., Lange, L. A., Kronmal, R. A., Heckbert, S. R., & Mukamal, K. J. (2018) · Clinical Cardiology · doi:10.1002/clc.22965 · Cited by 27
Vincentis, S. D., Decaroli, M. C., Fanelli, F., Diazzi, C., Mezzullo, M., Morini, F., Bertani, D. E., Milić, J., Carli, F., Cuomo, G., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0855 · Cited by 25
Deaths and Cardiovascular Events in Men Receiving Testosterone
Morgentaler, A., Traish, A. M., & Kacker, R. (2014) · JAMA · doi:10.1001/jama.2014.392 · Cited by 25
Corona, G., Rastrelli, G., Sparano, C., Carinci, V., Casella, G., Vignozzi, L., Sforza, A., & Maggi, M. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2337741 · Cited by 26
Testosterone and cardiovascular risk—deciphering the statistics
Morgentaler, A., & Kacker, R. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.24 · Cited by 24
Impact of recent FDA ruling on testosterone replacement therapy (TRT)
Metzger, S., & Burnett, A. L. “. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.09.08 · Cited by 24
Sex hormones affect endothelial lipase-mediated lipid metabolism and atherosclerosis
Wang, C., Niimi, M., Kitajima, S., Matsuhisa, F., Yan, H., Dong, S., Liang, J., & Fan, J. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1175-4 · Cited by 24
Lapauw, B., & Kaufman, J. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0394 · Cited by 24
Shores, M. M., Walsh, T. J., Korpak, A. M., Krakauer, C. A., Forsberg, C. W., Fox, A., Moore, K. P., Heckbert, S. R., Thompson, M. L., Smith, N. L., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020562 · Cited by 25
Cannarella, R., Gusmano, C., Leanza, C., Garofalo, V., Crafa, A., Barbagallo, F., Condorelli, R. A., Vignera, S. L., & Calogero, A. E. (2023) · Asian Journal of Andrology · doi:10.4103/aja202352 · Cited by 27
Testosterone therapy and prostate cancer—safety concerns are well founded
Klotz, L. H. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2014.338 · Cited by 24
Zhao, J. V., & Schooling, C. M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.174 · Cited by 24
Ghimire, A., Bisset, E. S., & Howlett, S. E. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0256-4 · Cited by 24
Obesity, Body Composition, and Sex Hormones: Implications for Cardiovascular Risk
Singh, P., Covassin, N., Marlatt, K. L., Gadde, K. M., & Heymsfield, S. B. (2021) · Comprehensive physiology · doi:10.1002/cphy.c210014 · Cited by 44
Traish, A. M. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00174.2016 · Cited by 23
Testosterone therapy and prostate cancer
Pastuszak, A. W., Rodríguez, K. M. G., Nguyen, T. M., & Khera, M. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.08.17 · Cited by 23
Male hypogonadism: therapeutic choices and pharmacological management
Vignera, S. L., Izzo, G., Emerenziani, G. P., Cannarella, R., Condorelli, R. A., Calogero, A. E., & Aversa, A. (2020) · Minerva Endocrinology · doi:10.23736/s0391-1977.20.03195-8 · Cited by 24
Leydig cell aging: Molecular mechanisms and treatments
Papadopoulos, V., & Zirkin, B. R. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2020.12.023 · Cited by 24
Grossmann, M., Anawalt, B. D., & Wu, F. C. W. (2014) · Clinical Endocrinology · doi:10.1111/cen.12594 · Cited by 23
Elsherbiny, A., Tricomi, M., Bhatt, D., & Dandapantula, H. K. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0838-x · Cited by 23
Gynecologic and andrologic dermatology and the metabolic syndrome
Roth, M. M., Leader, N. F., & Kroumpouzos, G. (2017) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2017.09.013 · Cited by 23
Miner, M. M., Morgentaler, A., Khera, M., & Traish, A. M. (2018) · Clinical Endocrinology · doi:10.1111/cen.13589 · Cited by 23
Finkelstein, J. S., Lee, H., Burnett‐Bowie, S. M., Darakananda, K., Gentile, E. C., Goldstein, D. W., Prizand, S. H., Krivicich, L. M., Taylor, A. P., Wulczyn, K. E., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa318 · Cited by 23
Syed, A. A. S., He, L., & Shi, Y. (2020) · Genes · doi:10.3390/genes11070721 · Cited by 25
Irrational Exuberance in Testosterone Prescribing: When Will the Bubble Burst?
Handelsman, D. J. (2015) · Medical Care · doi:10.1097/mlr.0000000000000416 · Cited by 22
Testosterone Therapy Among Prostate Cancer Survivors
Nguyen, T. M., & Pastuszak, A. W. (2016) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2016.06.005 · Cited by 22
Grober, E. D., Krakowsky, Y., Khera, M., Holmes, D. T., Jc, L., Grantmyre, J. E., Patel, P., Bebb, R. A., Fitzpatrick, R., Campbell, J. D., et al. (2021) · Canadian Urological Association Journal · doi:10.5489/cuaj.7252 · Cited by 26
Sexuality and Quality of Life in Aging: Implications for Practice
Buttaro, T. M., Koeniger‐Donohue, R., & Hawkins, J. W. (2014) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2014.04.008 · Cited by 22
Late onset hypogonadism of men is not equivalent to the menopause
Saad, F., & Gooren, L. J. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.06.016 · Cited by 22
Dias, J. P., Shardell, M. D., Carlson, O. D., Melvin, D., Caturegli, G., Ferrucci, L., Chia, C. W., Egan, J. M., & Basaria, S. (2017) · Andrology · doi:10.1111/andr.12284 · Cited by 22
Rais, M., Wilson, R. M., Urbanski, H. F., & Messaoudi, I. (2017) · GeroScience · doi:10.1007/s11357-017-9979-5 · Cited by 22
Testosterone replacement therapy and the risk of stroke in men: A systematic review
Loo, S. Y., Chen, B. Y., Yu, O. H. Y., Azoulay, L., & Renoux, C. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.08.013 · Cited by 22
Testosterone, frailty and physical function in older men
Hsu, B., Cumming, R. G., & Handelsman, D. J. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1475227 · Cited by 22
The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts
Kırlangıç, O. F., Yilmaz‐Oral, D., Kaya‐Sezginer, E., Toktanis, G., Tezgelen, A. S., Sen, E., Khanam, A., Öztekin, Ç. V., & Gür, S. (2020) · Sexual Medicine · doi:10.1016/j.esxm.2020.02.006 · Cited by 23
Wu, J., Hadoke, P. W. F., Mair, I., Lim, W. G., Miller, E., Denvir, M. A., & Smith, L. B. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu142 · Cited by 21
Hagihara, A., Onozuka, D., Ono, J., Nagata, T., & Hasegawa, M. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.05.003 · Cited by 21
Association between serum levels of testosterone and biomarkers of subclinical atherosclerosis
Rezanezhad, B., Borgquist, R., Willenheimer, R. B., & Elzanaty, S. (2017) · The Aging Male · doi:10.1080/13685538.2017.1412422 · Cited by 21
Cardiovascular and metabolic actions of the androgens: Is testosterone a Janus-faced molecule?
Stallone, J. N., & Oloyo, A. K. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115347 · Cited by 22
Testosterone Replacement Therapy: A Narrative Review with a Focus on New Oral Formulations
Bhat, S. Z., & Dobs, A. S. (2022) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2022.18.2.133 · Cited by 23
Kozloski, M., Schumm, L. P., & McClintock, M. K. (2014) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbu123 · Cited by 20
Testosterone therapy in the new era of Food and Drug Administration oversight
Desroches, B. R., Kohn, T. P., Welliver, C., & Pastuszak, A. W. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.03.13 · Cited by 21
Effects of testosterone and progressive resistance exercise on vascular function in older men
Hildreth, K. L., Schwartz, R. S., Griend, J. P. V., Kohrt, W. M., Blatchford, P. J., & Moreau, K. L. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00165.2018 · Cited by 21
Jasuja, G. K., & Rose, A. J. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4113-z · Cited by 19
Testosterone replacement in men with sexual dysfunction
Lee, H., Hwang, E. C., Oh, C. K., Lee, S., Yu, H. S., Lim, J. S., Kim, H. W., Walsh, T. J., Kim, M. H., Jung, J. H., et al. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013071.pub2 · Cited by 20
Transcatheter Aortic Valve Implantation in the Elderly: Who to Refer?
Finn, M. T., & Green, P. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2014.08.003 · Cited by 20
Recent advances in endocrine organoids for therapeutic application
Jeon, S., Lee, Y.-S., Oh, S. R., Jeong, J., Lee, D., So, K., & Hwang, N. S.-Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114959 · Cited by 20
Testosterone Therapy Is Associated With Increased Odds of Quadriceps Tendon Injury
Meghani, O., Albright, J. A., Testa, E. J., Arcand, M. A., Daniels, A. H., & Owens, B. D. (2023) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000002744 · Cited by 20
Deng, C., Zhang, Z., Li, H., Bai, P., Cao, X., & Dobs, A. S. (2018) · The Aging Male · doi:10.1080/13685538.2018.1479387 · Cited by 20
Opioid-Induced Hypogonadism in the United States
Baillargeon, J., Raji, M. A., Urban, R. J., López, D. S., Williams, S. B., Westra, J. R., & Kuo, Y. (2019) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2019.06.007 · Cited by 20
Lundy, S. D., Parekh, N. V., & Shoskes, D. A. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.03.006 · Cited by 21
From sex hormone decrease to hormonal treatment: impacts on cardiovascular risk with ageing
Fontaine, C., Gosset, A., Davezac, M., Buscato, M., Grouthier, V., Renault, M., Henrion, D., Trémollières, F., Schumacher, M., Lenfant, F., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf086 · Cited by 19
The identification and molecular mechanism of anti-stroke traditional Chinese medicinal compounds
Liu, J., Dai, S., Zheng, J., Guo, Y., Li, W., Li, G., & Huang, J. (2017) · Scientific Reports · doi:10.1038/srep41406 · Cited by 19
Cardiovascular effects of hormone therapy for prostate cancer
Mason, M. D., & Lester, J. F. (2015) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s50549 · Cited by 24
Hypogonadism and its treatment following ischaemic stroke in men with type 2 diabetes mellitus
Morgunov, L. Y., Денисова, И. А., Rozhkova, T. I., Stakhovskaya, L. V., & Skvortsova, V. I. (2018) · The Aging Male · doi:10.1080/13685538.2018.1487932 · Cited by 19
Marcelli, M., & Mediwala, S. N. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001233 · Cited by 23
Diagnosis and Treatment of Low Testosterone among Patients with End‐Stage Renal Disease
Bao, Y., & Johansen, K. L. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12318 · Cited by 18
Gore, A. C., Hall, J. E., & Hayes, F. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00037-5 · Cited by 19
Morimoto, M., Amano, Y., Oka, M., Harada, A., Fujita, H., Hikichi, Y., Tozawa, R., Yamaoka, M., & Hara, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189480 · Cited by 20
Wu, Y., & Sung, W. (2024) · Pharmaceuticals · doi:10.3390/ph17091233 · Cited by 19
Dogan, B. A., Karakılıç, E., Tuna, M. M., Arduç, A., Berker, D. S., & Güler, S. (2014) · Clinical Endocrinology · doi:10.1111/cen.12617 · Cited by 18
Management of male sexual dysfunction after cancer treatment
Kim, P., & Clavijo, R. I. (2020) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2020.08.006 · Cited by 22
Testosterone stimulates cholesterol clearance from human macrophages by activating LXRα
Kilby, E., Kelly, D. M., & Jones, T. H. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119040 · Cited by 17
Relationships between endogenous and exogenous testosterone and cardiovascular disease in men
Thirumalai, A., & Anawalt, B. D. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09752-7 · Cited by 20
Metadata
- Authors
- Vigen, R.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Vigen, Rebecca
- ORCID
- Vigen, Rebecca
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2013-11-06
- Volume
- 310
- Issue
- 17
- Pages
- 1829
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2132123717
- Cited by
- 1,003
- References
- 39
- Citations by year
- 2026: 25 · 2025: 45 · 2024: 48 · 2023: 62 · 2022: 52 · 2021: 52 · 2020: 60 · 2019: 70 · 2018: 87 · 2017: 101 · 2016: 96 · 2015: 136 · 2014: 162 · 2013: 5
- FWCI
- 104.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- testosterone replacement therapy, androgen deficiency, hypogonadism, all-cause mortality, myocardial infarction, ischemic stroke, cardiovascular outcomes, coronary artery disease, male veterans, coronary angiography, men's health, hormone replacement therapy, early trial termination, sex differences in cardiovascular risk
- MeSH terms
- Aged, Coronary Artery Disease, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Retrospective Studies, Risk, Testosterone, Veterans, Cohort Studies, Coronary Angiography, Stroke, Andropause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
